MARKET

GERN

GERN

Geron Corp
NASDAQ
3.300
-0.010
-0.30%
After Hours: 3.329 +0.029 +0.88% 19:57 03/28 EDT
OPEN
3.320
PREV CLOSE
3.310
HIGH
3.340
LOW
3.270
VOLUME
6.21M
TURNOVER
0
52 WEEK HIGH
3.735
52 WEEK LOW
1.640
MARKET CAP
1.94B
P/E (TTM)
-10.2262
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at GERN last week (0318-0322)?
Weekly Report · 3d ago
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
NASDAQ · 03/21 14:01
Geron announces pricing of $150M underwritten offering
Healthcare Geron announces pricing of $150M underwritten offering. Geron Corporation expects proceeds of ~$150M from the offering. The company expects to use the proceeds to fund the potential commercialization of imetelstat in the U.S. And EU.
Seeking Alpha · 03/19 13:21
Geron Corporation Announces Pricing Of $150M Underwritten Offering Of Common Stock And Pre-Funded Warrants
Geron Corporation announces pricing of an underwritten offering of 41,999,998 shares of its common stock. The company is a late-stage clinical biopharmaceutical company. The offering is expected to raise $150.0 million. Geron intends to use the proceeds to fund the development of imetelstat.
Benzinga · 03/19 13:07
STAT News' Adam Feuerstein Publishes "I Was Wrong About Geron's Blood Cancer Drug. Now, Is It A Takeover Target?"; Shares See Volume
I was wrong about Geron's effort to develop a blood cancer drug. The drug was never going to be approved, he says. A group of outside experts voted 12-2 in imetelstat’s favor. An FDA approval of the drug is now highly likely.
Benzinga · 03/18 13:08
Company News for Mar 18, 2024
NASDAQ · 03/18 12:48
Why Nuvei Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Shares of Nuvei Corp (NASDAQ:NVEI) rose sharply in today's pre-market trading. The company is in buyout talks with Advent International. Solidion Technology Inc. Shares gained 62.1% to $2.82 after surging around 34% on Friday.
Benzinga · 03/18 12:06
Logitech, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. Stock futures were mostly higher in today's pre-market trading. The Nasdaq futures gained by around 100 points on Monday. Shares of Logitech International S.A. (NASDAQ: LOGI) fell in today’s trading. B. Riley Financial, Inc. And Geron Corporation were among the big stocks recording losses.
Benzinga · 03/18 09:57
More
About GERN
Geron Corporation is a late-stage biopharmaceutical company. The Company is focused on the development and commercialization of imetelstat, a therapeutic for hematologic malignancies. The Company operates through a single segment, which is engaged in the development of therapeutic products for oncology. Imetelstat is a lipid conjugated 13mer oligonucleotide that the Company designed to be complementary to and bind with high affinity to the ribonucleic acid (RNA) template of telomerase, thereby directly inhibiting telomerase activity. Its lead indication for imetelstat is in low or intermediate-1 risk myelodysplastic syndromes (MDS). It is also engaged in the development of two indications, such as the treatment of adult patients with transfusion-dependent anemia due to lower risk MDS, and the treatment of adult patients with Intermediate-2 or High-Risk MF whose disease has relapsed after or is refractory to janus associate kinase inhibitor (JAK) inhibitor treatment.

Webull offers Geron Corp stock information, including NASDAQ: GERN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GERN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GERN stock methods without spending real money on the virtual paper trading platform.